Weekly Policy Update: Trump Administration Pulls Rebate Rule

Monday, July 15, 2019

Last week the Trump Administration withdrew their proposed rebate rule that would have required manufacturer rebates to be passed through to patients in Part D and other government programs.  

Weekly Policy Update: Drug Pricing Bills Pass Key Senate Committees

Monday, July 08, 2019


Weekly Policy Update: New Economic Forecast Indicates Increase in Expected Revenue Above the TABOR Cap

Thursday, June 20, 2019
Continue Reading

Weekly Policy Update: CBSA Submits Comment Letter to Senate Finance Committee’s Health Task Force Urging Repeal of the Medical Device Excise Tax

Friday, June 14, 2019


Weekly Policy Update: CBSA Attends the 2019 BIO International Convention

Monday, June 10, 2019

Last week CBSA President and CEO Jennifer Jones Paton and Vice President Emily Roberts attended the 2019 BIO International Convention in Philadelphia. The event brings together over 16,000 attendees from around the world for educational sessions, networking events, and partnering meetings. For the CBSA team, it’s a great opportunity to connect with industry partners, biotechnology companies, and other state associations to discuss collaboration opportunities and share best practices.  

Improving the Reimbursement Landscape for Medical Technology Innovators

Friday, May 24, 2019

CBSA continues to work with Congress and federal policymakers to improve the reimbursement landscape for medical technology innovators. Even when groundbreaking and innovative technologies meet FDA’s rigorous standards, device manufacturers face other significant hurdles in navigating the coverage and reimbursement process. In fact, many technology manufacturers do not pursue national coverage decisions because they are too time consuming and cumbersome.  

CMS Rolls Back Harmful Proposals in Medicare Part D

Monday, May 20, 2019


Weekly Policy Update: CMS Proposed Rule is a Step Forward for the Coverage of Breakthrough Technologies

Monday, May 13, 2019

In late April, the Centers for Medicare and Medicaid Services (CMS) publicly released its FY 2020 Inpatient Prospective Payment System (IPPS) Proposed Rule. The rule is a critical step forward for coverage and payment of medical devices, and makes it more likely that breakthrough products will be covered and adequately paid for by CMS.  

Weekly Policy Update: The Final Tally - 2019 Legislative Session Comes to a Close

Friday, May 03, 2019

CBSA has worked hard this session to advocate on behalf of the industry. We’ve worked with our members and partners to advance proposals that promote patient safety, protect patient access, and enhance workforce development efforts, while coordinating to convey concerns with problematic legislation and mitigate threats to the industry in Colorado. 

Weekly Policy Update: One Week Left - What Will Make It Across the Finish Line

Friday, April 26, 2019